tiprankstipranks
Trending News
More News >
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market

Ovid Therapeutics (OVID) Income Statement

Compare
1,682 Followers

Ovid Therapeutics Income Statement

Last quarter (Q3 2025), Ovid Therapeutics's total revenue was $132.00K, a decrease of -23.70% from the same quarter last year. In Q3, Ovid Therapeutics's net income was $-12.16M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 566.00K$ 392.00K$ 1.50M$ 208.38M$ 12.62M
Gross Profit
$ 566.00K$ 392.00K$ 1.50M$ 208.38M$ 12.62M
Operating Expenses
$ 62.45M$ 59.67M$ 57.05M$ 84.17M$ 94.05M
Depreciation and Amortization
$ 613.00K$ 568.00K$ 1.38M$ 237.08K$ 306.85K
EBITDA
$ -57.77M$ -57.01M$ -54.17M$ 124.45M$ -81.12M
Operating Income
$ -61.88M$ -59.28M$ -55.55M$ 124.21M$ -81.43M
Other Income/Expenses
$ 35.45M$ 6.94M$ 1.38M$ -45.69K$ 395.40K
Pretax Income
$ -26.43M$ -52.34M$ -54.17M$ 124.16M$ -81.04M
Net Income
$ -26.43M$ -52.34M$ -54.17M$ 122.83M$ -81.04M
Per Share Metrics
Basic EPS
$ -0.37$ -0.74$ -0.77$ 1.78$ -1.39
Diluted EPS
$ -0.37$ -0.74$ -0.77$ 1.76$ -1.39
Weighted Average Shares Outstanding
70.91M 70.58M 70.42M 67.48M 58.45M
Weighted Average Shares Outstanding (Diluted)
70.91M 70.58M 70.42M 68.07M 58.45M
Currency in USD

Ovid Therapeutics Earnings and Revenue History